Psilocybin therapy for PTSD in Dutch veterans
Part of Mental health clinical trials.
This trial tests whether a psychedelic drug called psilocybin, given alongside talking therapy, can help veterans with long-lasting PTSD feel better. It may offer a new path for people whose symptoms haven't improved with other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You are a veteran of the Dutch armed forces.
- You have been diagnosed with PTSD that hasn't improved with standard treatments.
- You can read and speak Dutch fluently.
- You have a body mass index (BMI) over 18 — this is a measure of healthy weight.
- You can swallow pills and agree to have study visits recorded on video.
- You can name a support person (like a relative or close friend) who the study team can contact if you become unwell.
- You don't have any heart condition or high blood pressure that would make a temporary rise in blood pressure unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether high-dose MDMA, given during intensive inpatient therapy, can help people with PTSD that hasn't improved with other treatments. It takes place at a specialized trauma center and involves several therapy sessions with the drug.
This study tests whether a guided psilocybin session can help veterans heal from trauma-related PTSD. If you're a veteran with PTSD, you may be able to join.
This trial tests a type of therapy that uses psilocybin (a safe, natural substance found in certain mushrooms) to help people with PTSD. It combines talk therapy with the medicine to see if it can reduce trauma symptoms.
This study tests if psilocybin-assisted group therapy can help people with moderate to severe PTSD. It is for veterans, first responders, female survivors of sexual violence, or Indigenous individuals.
This study tests whether a combination of two investigational drugs, psilocybin and MDMA, can help veterans with post-traumatic stress disorder (PTSD). You would receive the drugs in a controlled setting and be monitored closely.
This study tests whether a drug called psilocybin (the active ingredient in 'magic mushrooms') combined with therapy can help treat PTSD in military personnel and veterans. You'll receive the drug during a supervised session, along with talk therapy, to see if it reduces PTSD symptoms.
Hear when a new Posttraumatic Stress Disorder (PTSD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.